Waters (WAT) Scheduled to Post Quarterly Earnings on Tuesday

Waters (NYSE:WATGet Free Report) is scheduled to release its earnings data before the market opens on Tuesday, February 6th. Analysts expect Waters to post earnings of $3.56 per share for the quarter. Waters has set its Q4 2023 guidance at $3.52-$3.62 EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings data on Tuesday, November 7th. The medical instruments supplier reported $2.84 EPS for the quarter, beating analysts’ consensus estimates of $2.56 by $0.28. The company had revenue of $711.69 million during the quarter, compared to analysts’ expectations of $722.27 million. Waters had a return on equity of 102.22% and a net margin of 21.80%. Waters’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.64 earnings per share. On average, analysts expect Waters to post $12 EPS for the current fiscal year and $12 EPS for the next fiscal year.

Waters Stock Down 1.1 %

Waters stock opened at $320.74 on Monday. The stock has a market cap of $18.97 billion, a PE ratio of 29.13, a price-to-earnings-growth ratio of 6.78 and a beta of 0.92. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.46 and a current ratio of 2.19. Waters has a one year low of $231.90 and a one year high of $346.24. The stock has a fifty day moving average of $310.60 and a 200 day moving average of $283.95.

Hedge Funds Weigh In On Waters

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. First Capital Advisors Group LLC. bought a new stake in shares of Waters in the 2nd quarter valued at approximately $26,000. Harbour Investments Inc. raised its holdings in shares of Waters by 11,000.0% in the second quarter. Harbour Investments Inc. now owns 111 shares of the medical instruments supplier’s stock worth $30,000 after buying an additional 110 shares during the period. Clear Street Markets LLC raised its holdings in shares of Waters by 94.9% in the first quarter. Clear Street Markets LLC now owns 115 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 56 shares during the period. Advisory Services Network LLC raised its holdings in shares of Waters by 64.2% in the first quarter. Advisory Services Network LLC now owns 133 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 52 shares during the period. Finally, Tyler Stone Wealth Management purchased a new stake in shares of Waters in the second quarter worth approximately $40,000. 94.01% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Citigroup upped their price objective on Waters from $265.00 to $300.00 and gave the company a “neutral” rating in a research report on Monday, December 11th. TheStreet upgraded Waters from a “c+” rating to a “b-” rating in a research report on Wednesday, December 13th. Wolfe Research began coverage on Waters in a research report on Wednesday, December 13th. They issued a “peer perform” rating for the company. Stifel Nicolaus reduced their price target on Waters from $305.00 to $290.00 and set a “hold” rating for the company in a research report on Wednesday, November 8th. Finally, Barclays upped their price target on Waters from $230.00 to $275.00 and gave the stock an “underweight” rating in a research report on Thursday, January 25th. One investment analyst has rated the stock with a sell rating and eight have issued a hold rating to the stock. According to data from MarketBeat.com, Waters has an average rating of “Hold” and a consensus target price of $285.38.

Check Out Our Latest Research Report on Waters

About Waters

(Get Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also

Earnings History for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.